Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I - PubMed (original) (raw)

Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I

K Overturf et al. Nat Genet. 1996 Mar.

Erratum in

• Nat Genet 1996 Apr;12(4):458

Abstract

Current strategies for hepatic gene therapy are either quantitatively inefficient or suffer from lack of permanent gene expression. We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. As few as 1,000 transplanted wild-type hepatocytes were able to repopulate mutant liver, demonstrating their strong competitive growth advantage. Mutant hepatocytes corrected in situ by retroviral gene transfer were also positively selected. In mutant animals treated by multiple retrovirus injections >90% of hepatocytes became FAH positive and liver function was restored to normal. Our results demonstrate that in vivo selection is a useful strategy for hepatic gene therapy and may lead to effective treatment of human HT1 by retroviral gene transfer.

PubMed Disclaimer

Comment in

• Round two for liver gene therapy.
  Wilson JM. Wilson JM. Nat Genet. 1996 Mar;12(3):232-3. doi: 10.1038/ng0396-232. Nat Genet. 1996. PMID: 8589710 No abstract available.

Similar articles

• Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
  Grompe M, Lindstedt S, al-Dhalimy M, Kennaway NG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M. Grompe M, et al. Nat Genet. 1995 Aug;10(4):453-60. doi: 10.1038/ng0895-453. Nat Genet. 1995. PMID: 7545495
• Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
  Overturf K, Al-Dhalimy M, Manning K, Ou CN, Finegold M, Grompe M. Overturf K, et al. Hum Gene Ther. 1998 Feb 10;9(3):295-304. doi: 10.1089/hum.1998.9.3-295. Hum Gene Ther. 1998. PMID: 9508047
• Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity.
  Jacobs SM, van Beurden DH, Klomp LW, Berger R, van den Berg IE. Jacobs SM, et al. Pediatr Res. 2006 Mar;59(3):365-70. doi: 10.1203/01.pdr.0000198810.57642.b4. Pediatr Res. 2006. PMID: 16492973
• Tyrosine and its catabolites: from disease to cancer.
  Tanguay RM, Jorquera R, Poudrier J, St-Louis M. Tanguay RM, et al. Acta Biochim Pol. 1996;43(1):209-16. Acta Biochim Pol. 1996. PMID: 8790725 Review.
• Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
  St-Louis M, Tanguay RM. St-Louis M, et al. Hum Mutat. 1997;9(4):291-9. doi: 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9. Hum Mutat. 1997. PMID: 9101289 Review.

Cited by

• In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1.
  Rivest JF, Carter S, Goupil C, Antérieux P, Cyr D, Ung RV, Dal Soglio D, Mac-Way F, Waters PJ, Paganelli M, Doyon Y. Rivest JF, et al. Genetics. 2024 Oct 7;228(2):iyae139. doi: 10.1093/genetics/iyae139. Genetics. 2024. PMID: 39178380 Free PMC article.
• Cell competition in primary and metastatic colorectal cancer.
  van Luyk ME, Krotenberg Garcia A, Lamprou M, Suijkerbuijk SJE. van Luyk ME, et al. Oncogenesis. 2024 Jul 26;13(1):28. doi: 10.1038/s41389-024-00530-5. Oncogenesis. 2024. PMID: 39060237 Free PMC article. Review.
• Hepatocytes differentiate into intestinal epithelial cells through a hybrid epithelial/mesenchymal cell state in culture.
  Miura S, Horisawa K, Iwamori T, Tsujino S, Inoue K, Karasawa S, Yamamoto J, Ohkawa Y, Sekiya S, Suzuki A. Miura S, et al. Nat Commun. 2024 May 15;15(1):3940. doi: 10.1038/s41467-024-47869-2. Nat Commun. 2024. PMID: 38750036 Free PMC article.
• Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight.
  Zhang Z, Zhang S, Wong HT, Li D, Feng B. Zhang Z, et al. BioDrugs. 2024 May;38(3):369-385. doi: 10.1007/s40259-024-00654-5. Epub 2024 Mar 15. BioDrugs. 2024. PMID: 38489061 Free PMC article. Review.
• "Small Hepatocytes" in the Liver.
  Mitaka T, Ichinohe N, Tanimizu N. Mitaka T, et al. Cells. 2023 Nov 27;12(23):2718. doi: 10.3390/cells12232718. Cells. 2023. PMID: 38067145 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal